A detailed history of Capstone Investment Advisors, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 300 shares of TECH stock, worth $21,909. This represents 0.0% of its overall portfolio holdings.

Number of Shares
300
Holding current value
$21,909
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$70.96 - $82.35 $248,785 - $288,719
3,506 New
3,506 $280,000
Q1 2024

May 01, 2024

BUY
$65.98 - $77.09 $256,464 - $299,648
3,887 New
3,887 $273,000
Q3 2023

Nov 13, 2023

BUY
$67.52 - $89.42 $449,413 - $595,179
6,656 Added 354.23%
8,535 $580,000
Q2 2023

Aug 10, 2023

BUY
$73.76 - $85.98 $138,595 - $161,556
1,879 New
1,879 $153,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.86B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.